1-115725557-GAAAAAAAAAAAAAAA-GAAAAAAAA
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001232.4(CASQ2):c.738-11_738-5delTTTTTTT variant causes a splice region, intron change. The variant allele was found at a frequency of 0.00124 in 1,401,858 control chromosomes in the GnomAD database, including 8 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0051 ( 6 hom., cov: 0)
Exomes 𝑓: 0.00091 ( 2 hom. )
Consequence
CASQ2
NM_001232.4 splice_region, intron
NM_001232.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.12
Publications
3 publications found
Genes affected
CASQ2 (HGNC:1513): (calsequestrin 2) The protein encoded by this gene specifies the cardiac muscle family member of the calsequestrin family. Calsequestrin is localized to the sarcoplasmic reticulum in cardiac and slow skeletal muscle cells. The protein is a calcium binding protein that stores calcium for muscle function. Mutations in this gene cause stress-induced polymorphic ventricular tachycardia, also referred to as catecholaminergic polymorphic ventricular tachycardia 2 (CPVT2), a disease characterized by bidirectional ventricular tachycardia that may lead to cardiac arrest. [provided by RefSeq, Jul 2008]
CASQ2 Gene-Disease associations (from GenCC):
- catecholaminergic polymorphic ventricular tachycardiaInheritance: AD, AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- catecholaminergic polymorphic ventricular tachycardia 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Genomics England PanelApp
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 1-115725557-GAAAAAAA-G is Benign according to our data. Variant chr1-115725557-GAAAAAAA-G is described in CliVar as Benign/Likely_benign. Clinvar id is 502421.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-115725557-GAAAAAAA-G is described in CliVar as Benign/Likely_benign. Clinvar id is 502421.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-115725557-GAAAAAAA-G is described in CliVar as Benign/Likely_benign. Clinvar id is 502421.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-115725557-GAAAAAAA-G is described in CliVar as Benign/Likely_benign. Clinvar id is 502421.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-115725557-GAAAAAAA-G is described in CliVar as Benign/Likely_benign. Clinvar id is 502421.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-115725557-GAAAAAAA-G is described in CliVar as Benign/Likely_benign. Clinvar id is 502421.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-115725557-GAAAAAAA-G is described in CliVar as Benign/Likely_benign. Clinvar id is 502421.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00506 (577/114004) while in subpopulation AFR AF = 0.0163 (503/30844). AF 95% confidence interval is 0.0151. There are 6 homozygotes in GnomAd4. There are 295 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR,AD gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00503 AC: 574AN: 114034Hom.: 6 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
574
AN:
114034
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000907 AC: 1168AN: 1287854Hom.: 2 AF XY: 0.000988 AC XY: 634AN XY: 641506 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
1168
AN:
1287854
Hom.:
AF XY:
AC XY:
634
AN XY:
641506
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
386
AN:
28294
American (AMR)
AF:
AC:
27
AN:
31816
Ashkenazi Jewish (ASJ)
AF:
AC:
4
AN:
22758
East Asian (EAS)
AF:
AC:
26
AN:
36454
South Asian (SAS)
AF:
AC:
376
AN:
72620
European-Finnish (FIN)
AF:
AC:
6
AN:
37118
Middle Eastern (MID)
AF:
AC:
7
AN:
3680
European-Non Finnish (NFE)
AF:
AC:
257
AN:
1001654
Other (OTH)
AF:
AC:
79
AN:
53460
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.334
Heterozygous variant carriers
0
65
129
194
258
323
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00506 AC: 577AN: 114004Hom.: 6 Cov.: 0 AF XY: 0.00558 AC XY: 295AN XY: 52884 show subpopulations
GnomAD4 genome
AF:
AC:
577
AN:
114004
Hom.:
Cov.:
0
AF XY:
AC XY:
295
AN XY:
52884
show subpopulations
African (AFR)
AF:
AC:
503
AN:
30844
American (AMR)
AF:
AC:
24
AN:
10306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2992
East Asian (EAS)
AF:
AC:
4
AN:
3814
South Asian (SAS)
AF:
AC:
21
AN:
3260
European-Finnish (FIN)
AF:
AC:
0
AN:
3528
Middle Eastern (MID)
AF:
AC:
0
AN:
224
European-Non Finnish (NFE)
AF:
AC:
18
AN:
56720
Other (OTH)
AF:
AC:
7
AN:
1548
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.569
Heterozygous variant carriers
0
22
44
65
87
109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Jun 06, 2017
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Catecholaminergic polymorphic ventricular tachycardia 2 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Catecholaminergic polymorphic ventricular tachycardia 1;C2677794:Catecholaminergic polymorphic ventricular tachycardia 2 Benign:1
Sep 24, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Oct 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.